Home > National Drug Code (NDC) > Treatment Set TS346790

Treatment Set TS346790 - 49288-0861-3 - (Treatment Set TS346790)

Alphabetical Index


Drug Information Labeler Information Package Information NDC Record

Drug Information of Treatment Set TS346790

Product NDC: 49288-0861
Proprietary Name: Treatment Set TS346790
Non Proprietary Name: Treatment Set TS346790
Active Ingredient(s): .002; .002; 4000; .002; .001; .001; 400; 160; .002; .0004; .00008; 160; .002; .002; .002; .002; .0004    g/mL; g/mL; [AU]/mL; g/mL; g/mL; g/mL; [BAU]/mL; [BAU]/mL; g/mL; g/mL; g/mL; [BAU]/mL; g/mL; g/mL; g/mL; g/mL; g/mL & nbsp;   Treatment Set TS346790
Administration Route(s): INTRADERMAL; SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Treatment Set TS346790

Product NDC: 49288-0861
Labeler Name: Antigen Laboratories, Inc.
Product Type: NON-STANDARDIZED ALLERGENIC
FDA Application Number: BLA102223
Marketing Category: BLA
Start Marketing Date: 19861031

Package Information of Treatment Set TS346790

Package NDC: 49288-0861-3
Package Description: 10 mL in 1 VIAL, MULTI-DOSE (49288-0861-3)

NDC Information of Treatment Set TS346790

NDC Code 49288-0861-3
Proprietary Name Treatment Set TS346790
Package Description 10 mL in 1 VIAL, MULTI-DOSE (49288-0861-3)
Product NDC 49288-0861
Product Type Name NON-STANDARDIZED ALLERGENIC
Non Proprietary Name Treatment Set TS346790
Dosage Form Name INJECTION, SOLUTION
Route Name INTRADERMAL; SUBCUTANEOUS
Start Marketing Date 19861031
Marketing Category Name BLA
Labeler Name Antigen Laboratories, Inc.
Substance Name ACER NEGUNDO POLLEN; AMARANTHUS RETROFLEXUS POLLEN; AMBROSIA ARTEMISIIFOLIA POLLEN; AVENA SATIVA POLLEN; CARYA ILLINOINENSIS POLLEN; CARYA TOMENTOSA POLLEN; CYNODON DACTYLON POLLEN; FESTUCA PRATENSIS POLLEN; FRAXINUS AMERICANA POLLEN; JUNIPERUS VIRGINIANA POLLEN; PASCOPYRUM SMITHII POLLEN; PHLEUM PRATENSE POLLEN; PLANTAGO LANCEOLATA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POPULUS DELTOIDES POLLEN; RUMEX ACETOSELLA POLLEN; SORGHUM HALEPENSE POLLEN
Strength Number .002; .002; 4000; .002; .001; .001; 400; 160; .002; .0004; .00008; 160; .002; .002; .002; .002; .0004
Strength Unit g/mL; g/mL; [AU]/mL; g/mL; g/mL; g/mL; [BAU]/mL; [BAU]/mL; g/mL; g/mL; g/mL; [BAU]/mL; g/mL; g/mL; g/mL; g/mL; g/mL
Pharmaceutical Classes Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Increased Histamine Release [PE],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient]

Complete Information of Treatment Set TS346790


Featured Tools

NDC Directory

Pill Identifier

Latest Updates

FDA Consumer Updates Drug Recalls Medwatch Safety Alerts

General Information

Medical Words Medical Acronyms
© 2024 - Pharmaguru.com. All rights reserved.